Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,481 across all filing types
Latest filing 2023-12-05 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 4 December 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving a 'person discharging managerial responsibilities' (Ognian Donev, Executive director and chairman of the Board of directors of Sopharma AD) regarding the sale ('Sell') of financial instruments (Warrants). This structure, focusing on insider transactions, position, and transaction details (price/volume), is characteristic of regulatory filings mandated when directors trade company securities. This directly matches the definition for Director's Dealing (DIRS).
2023-12-05 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 1 December 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving shares ('Shares, ISIN № BG11SOSOBT18') conducted by a person closely associated with management ('Donev Investments Holding AD' associated with 'Ognian Donev' who is an Executive director and chairman of the Board of directors of Sopharma AD). The nature of the transaction is explicitly stated as 'Buy'. This structure—reporting personal share transactions by directors or closely associated persons—is characteristic of insider trading disclosures, often mandated by regulations like MAR (Market Abuse Regulation) in Europe. Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate classification for reporting personal share transactions by company directors and executives.
2023-12-04 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) ą 596/2014 of the European Parliament and of the Council of April 16, 2014 from 1 December 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving a 'person discharging managerial responsibilities' (Ognian Donev, an Executive director and chairman of the Board of directors of Sopharma AD) regarding the purchase ('Buy') of company shares. This structure, focusing on transactions by directors and executives, directly corresponds to the definition of Director's Dealing reports, which track insider trades. Reviewing the filing definitions: - 10-K/AR/IR are comprehensive financial reports. - ER/MDA are earnings-related. - The content is clearly about insider trading/share transactions by management. - Definition 9, Director's Dealing (DIRS), covers 'Report of personal share transactions by company directors and executives (insider trades)'. This is the most accurate classification.
2023-12-04 English
Treasury shares
Transaction in Own Shares Classification · 100% confidence The document is a 'Current report' dated December 4, 2023, specifically titled 'Treasury shares'. The content explicitly states that the Company 'bought 66 000 own shares' and details the total number of treasury shares held. This directly corresponds to the definition of a report concerning the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The short length (679 chars) confirms it is a direct announcement, not a comprehensive report.
2023-12-04 English
Consolidated financial report as at 30 September 2023
Regulatory Filings Classification · 19% confidence
2023-11-29 Polish
Minutes of the Extraordinary General Meeting of Shareholders of Sopharma AD, held on 24 November 2023
AGM Information Classification · 19% confidence
2023-11-24 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.